A meta-analysis targeting acute pancreatitis revealed that the sensitivity and specificity of PCT were lower than those of other biomarkers such as CRP or fecal calprotectin; however, it serves as a helpful adjunct in certain clinical scenarios to make appropriate treatment decisions [28]. This evidence concerns the gene CRP and acute pancreatitis.